Search

HCW Biologics announced the publication of a scientific paper, authored by the Company's scientific research team in the peer-reviewed journal, Molecular Therapy. Entitled, 'Bifunctional TGF-beta trap/IL-15 Protein Complex Elicits Potent [...]

Selecta Biosciences announced the peer-reviewed publication of a study investigating the effects of ImmTOR nanoparticles in generating a tolerogenic environment in the liver. The data, published in a Frontiers in [...]

Evaxion Biotech announced a presentation by Jens Kringelum, PhD, Evaxion's Director in Genomic Immuno-Oncology, at the 4th Neoantigen Summit Europe, being held virtually April 20-22, focusing on 'AI in personalized [...]

Sana Biotechnology announced that Nature Communications has published a paper titled 'Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice.' The preclinical [...]

Autolus Therapeutics announced the publication of a paper in Molecular Therapy titled 'Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.' The company said, 'While [...]

Poseida Therapeutics announced a peer-reviewed publication highlighting the potential of its proprietary Cas-CLOVER Site-specific Gene Editing System as a high-efficiency platform for the production of allogeneic CAR-T cells. The paper [...]

HOOKIPA Pharma announced a publication in the peer reviewed, open access journal OncoImmunology of a paper on HB-201, an arenavirus vector-based immunotherapy for Human Papillomavirus 16-positive cancers currently in clinical [...]

HOOKIPA Pharma announced a publication in the peer reviewed, open access journal OncoImmunology of a paper on HB-201, an arenavirus vector-based immunotherapy for Human Papillomavirus 16-positive cancers currently in clinical [...]

Cue Biopharma announced the peer-reviewed publication of preclinical data focused on the in vivo detection of tumor antigen-specific T cells in a paper published in Nature Methods titled, 'In vivo [...]

GeoVax Labs announced publication of its article entitled 'A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge.' The paper appears in [...]

TCR2 Therapeutics announced online publication of preclinical data in Nature Communications. The paper is entitled, 'Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response,' and shows [...]

Aduro Biotech announced the publication of a peer reviewed paper in Leukemia authored by scientists from the Dana Farber Cancer Institute and Aduro as part of their ongoing collaboration to [...]

By a News Reporter-Staff News Editor at Women's Health Weekly -- TapImmune Inc. (OTCBB: TPIV) is pleased to announce the January publication of a paper titled 'Enzymatic Discovery of a [...]

'Primary tumors that originated from the pterygopalatine fossa are seen rarely. In this paper, the case of a 69-year-old woman who complained of a 2-month history of headache, extending to [...]

Nuking Listerium monocytogenes Radiation-killed bacteria can elicit T-cell immune response By ANETTE BREINDL Medical Device Daily Science Editor Here comes the neutron bomb for vaccines. A paper published in the [...]

The Wistar Institute's David B. Weiner, Ph.D. Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research and his lab [...]

The Wistar Institute's David B. Weiner, Ph.D. Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research and his lab [...]

Gamma-delta ([gamma][delta]) T cells make up on average 4-5% of T cells founc in human peripheral blood (1). Two different types predominate; one that is largely found in organs and [...]

2024 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Chronic Lymphocytic Leukemia. According to [...]

CERo Therapeutics Holdings provides shareholders with a corporate update reviewing activities since its entering the public market. CERo Chairman and CEO Brian G. Atwood comments, 'CERo has undergone significant transformation [...]

Autolus Therapeutics announced a publication in Blood Cancer Journal entitled 'Dual T-cell constant beta chain and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry.' Diagnosing leukemic T-cell [...]

2024 MAR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing [...]

There is no doubt that chimeric antigen receptor (CAR) T-cell therapies have had a tremendous positive impact on patients that have received them; however, autologous cell therapies produced in centralized [...]

Smith, Kendall Arthur THE INTERLEUKIN REVOLUTION (NonFiction Nonfiction) Smith looks back on his efforts to elucidate the immune system before his rivals beat him to it in this candid memoir. [...]

A new tool to rapidly grow cancer-killing white blood cells could advance the availability of immunotherapy, a promising therapy which harnesses the power of the body's immune response to target [...]

2023 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on cell therapy. According to news reporting out [...]

2023 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Cell Therapy. According [...]

Artiva Biotherapeutics, a clinical stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-based therapies, reported that the U.S. Food and Drug Administration (FDA) has [...]

CoImmune, Inc., a clinical stage immuno-oncology company, announced it has exercised its option to obtain an exclusive license in the Delta-like Ligand 3 (DLL3)-targeted, allogeneic Chimeric Antigen Receptor-Cytokine Induced Killer [...]

Experts believe it is likely cancer cells are more common in the body than previously thought, but typically caught early and removed in the body's cancer-immune cycle. When the system [...]

Experts believe it is likely cancer cells are more common in the body than previously thought, but typically caught early and removed in the body's cancer-immune cycle. When the system [...]

Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, announced that the Company's Investigational New Drug [...]

2023 MAR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell [...]

2023 MAR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on clinical and experimental immunology is now available. According [...]

BioNTech SE presented what it calls 'positive' follow-up data from its ongoing first-in-human Phase 1/2 trial evaluating the safety and efficacy of the company's novel CAR-T cell therapy candidate, BNT211, [...]

Oncolytics announced the publication of preclinical data demonstrating the synergistic anti-cancer activity of pelareorep combined with chimeric antigen receptor (CAR) T cell therapy in solid tumors. Key data and conclusions [...]

is senior vice-president and head of cell and gene technologies at Lonza Pharma and Biotech. The cell and gene therapy industry is at major inflection point, as therapies move out [...]

India, Sept. 2 -- Vaccines train the immune system to recognise and respond to a particular pathogen, without first having to be infected by it Over the past year or [...]

Hookipa Pharma announced that pre-clinical data on its replicating Lymphocytic choriomeningitis, or LCMV, arenaviral-based immunotherapeutic has been published in the peer-reviewed journal, Nature Communications. The data demonstrate that Hookipa's LCMV-based [...]

TScan Therapeutics announced that Gavin MacBeath, Ph.D., Chief Scientific Officer at TScan, will present the findings of TScan's work to discover the targets of T cells in recovering COVID-19 patients [...]

Rubius Therapeutics announced the publication of preclinical data in the peer-reviewed journal Cancer Immunology, Immunotherapy, for its lead clinical oncology program, RTX-240, for the treatment of adults with advanced solid [...]

Rubius Therapeutics announced the publication of preclinical data in the peer-reviewed journal Nature Communications, for its lead artificial antigen-presenting cell program, RTX-321, for the potential treatment of human papillomavirus 16-positive [...]

2021 MAY 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on chemotherapy. According to news originating from Chongqing, [...]

2020 DEC 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Oncology - Peripheral T-Cell Lymphoma. According to [...]

Vir Biotechnology announced the publication of preclinical research in an influenza animal model highlighting a new mechanism for enhancing the efficacy of monoclonal antibodies to treat viral infection and induce [...]

2020 SEP 10 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Compass Therapeutics, Inc. a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage [...]

2020 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Piper Sandler analyst Christopher Raymond noted that Inovio shares are up by a double digit percentage on the Nature Communications publication of preclinical data on the company's CoV-19 DNA vaccine [...]

NEC Corp. reported analysis results from efforts using AI prediction platforms to design blueprints for SARS-CoV-2 vaccines that can drive potent T-cell responses in the majority of the global population. [...]

2019 DEC 26 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- SEATTLE -- What if a metal that's already used to repair broken bones, straighten [...]